Prometheus Biosciences, Inc.
RXDXDelisted Jun 16, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001718852
Prometheus Biosciences, Inc. was delisted on Jun 16, 2023; its insiders filed their last Form 4 on Jun 16, 2023; 220 institutions reported holding it in 13F filings for Q1 2023, worth $4.35B in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Prometheus Biosciences, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 116 | 144 | +28 |
| Shares | 30.8M | 32.9M | +2.04M (+6.6%) |
| Value | $869.7M | $1.94B | +$1.07B (+122.9%) |
New holders (46)
Institutions that held Prometheus Biosciences, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (18)
Institutions that held Prometheus Biosciences, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Citadel Advisors LLC | 647,703 | $18.3M |
| Norges Bank | 488,745 | $13.8M |
| Marshall Wace, LLP | 311,670 | $8.80M |
| 5AM Venture Management, LLC | 182,370 | $5.15M |
| Octagon Capital Advisors LP | 80,000 | $2.26M |
| Weiss Multi-Strategy Advisers LLC | 79,757 | $2.25M |
| HRT Financial LP | 45,967 | $1.30M |
| Altium Capital Management LP | 39,000 | $1.10M |
| Long Focus Capital Management, LLC | 35,000 | $988.0K |
| Gyon Technologies Capital Management, LP | 28,532 | $805.0K |
| UBS Oconnor LLC | 24,000 | $678.0K |
| Graham Capital Management, L.P. | 23,294 | $657.0K |
| Jump Financial, LLC | 19,200 | $542.0K |
| Simplex Trading, LLC | 11,448 | $323.0K |
| Jane Street Group, LLC | 10,416 | $294.0K |
| Dynamic Technology Lab Private Ltd | 8,130 | $230.0K |
| Quantbot Technologies LP | 5,158 | $145.0K |
| Captrust Financial Advisors | 7 | $0 |